Log in to your Inderes Free account to see all free content on this page.
Simris Group
0.10 SEK
-5.19 %
Less than 1K followers
SIMRIS B
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Valuation
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Simris Group
EV/S
Median 2019-2021
P/B
Median 2019-2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Share price (SEK) | 1.42 | 0.65 | 0.49 | 0.24 | 0.23 | 0.08 | 0.04 |
| Shares | 25.7 | 64.4 | 119.1 | 188.2 | 348.1 | 348.1 | 842.1 |
| Market cap | 36.6 | 42.0 | 58.1 | 45.3 | 78.3 | 26.5 | 36.0 |
| Enterprise value | 28.7 | 25.5 | 57.2 | - | - | - | - |
| EV/S | 16.5 | 11.8 | 9.3 | - | - | - | - |
| EV/EBITDA | neg. | neg. | neg. | - | - | - | - |
| EV/EBIT | neg. | neg. | neg. | - | - | - | - |
| P/E | neg. | neg. | neg. | neg. | neg. | neg. | neg. |
| P/B | 1.01 | 0.88 | 3.19 | 1.97 | 3.06 | 4.70 | -76.69 |
| P/S | 21.0 | 19.4 | 9.5 | 11.1 | 18.0 | 9.2 | 22.3 |
| Dividend yield | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % | 0.0 % |
| Equity ratio | 67.9 % | 83.1 % | 62.4 % | 12.4 % | 14.7 % | 3.6 % | -0.3 % |
| Gearing ratio | - | - | - | - | - | - | - |
Login required
This content is only available for logged in users